|
New York Times: Merck had earlier Vioxx info
Newspaper says drug maker had preliminary results from earlier study that showed heart complications.
November 18, 2004: 7:47 AM EST
Quiet scientist no more
By Rita Rubin, USA TODAY
"FDA made me into a whistle-blower," Graham, a scientist in the Food and Drug Administration's Office of Drug Safety, said in a three-hour interview Saturday at a coffee shop near his home.
The Boston Globe :Vioxx Malpractice
November 8, 2004
IN SEPTEMBER, Merck & Co. pulled its blockbuster pain reliever for arthritis, Vioxx, from the market when a study showed that it caused heart attacks and strokes in some cases.
FOOD AND DRUG ADMINISTRATION ON ZYPREXA
2004 Safety Alert: Zyprexa (olanzapine)
The following information is from Eli Lilly and Company.
The New York Times
National Briefing Science and Health: New Risk From Hormone Replacement
October 6, 2004
Los Angeles Times
February 12, 2004
Consumers Sue Wells Fargo, Bank of America
California
Litigation: TV Suit, Class Action, Prayer Lunches and More
Andrew White jumps networks; a small firm takes on big game.
By Gail Diane Cox, The National Law Journal, February 6,
2001
California
Fen-Phen Litigation Update
Approximately 650 lawsuits have been filed statewide against the
manufacturers and distributors of phentermine, fenfluramine and
dexfenfluramine, the prescribing doctors and diet centers which
dispensed the diet drugs.
Firm
agrees to compensate adjustors for earthquake OT
By Virginia McCrum, Pasadena Star-News, February 01, 2001
|
